TopFunds

UnitedHealth Group

NYSE: UNH

Stock price

401.43 USD

(+0%) TODAY

Medical - Healthcare Plans
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
6
7.3
10.7
12.2
14.3
16
18.1
21.2
23.9
15.5
13.2
8.2%
02Free cash flow per share
8.5
8.4
11.7
13.9
17
20.9
20.8
24.6
27.4
22.3
17.7
7.6%
03Dividends per share
1.9
2.4
2.9
3.5
4.1
4.8
5.6
6.4
7.3
8.2
8.7
16.6%
04Dividends payout, %
30.7%
32.2%
26.3%
27.7%
28.4%
29.8%
30.6%
29.8%
30.2%
52.3%
65.7%
7.9%
PROFIT AND LOSS STATEMENT
05Revenue
157,107
184,840
201,159
226,247
242,155
257,141
287,597
324,162
371,622
400,278
447,567
11%
06% Change
-
-
-
-
-
-
-
-
-
-
-
11%
07Cost of revenue
(120,081)
(141,454)
(154,148)
(172,401)
(184,557)
(190,141)
(217,945)
(244,545)
(280,664)
(310,879)
(364,650)
11.8%
08Gross profit
37,026
43,386
47,011
53,846
57,598
67,000
69,652
79,617
90,958
89,399
82,917
8.4%
09% Margin
23.6%
23.5%
23.4%
23.8%
23.8%
26.1%
24.2%
24.6%
24.5%
22.3%
18.5%
23.5% A
10Operating expenses
(26,005)
(30,456)
(31,802)
(36,502)
(37,913)
(44,595)
(45,682)
(51,182)
(58,600)
(57,112)
(63,953)
9.4%
11% of Revenue
(16.6)%
(16.5)%
(15.8)%
(16.1)%
(15.7)%
(17.3)%
(15.9)%
(15.8)%
(15.8)%
(14.3)%
(14.3)%
(15.8)% A
12Operating Income
11,021
12,930
15,209
17,344
19,685
22,405
23,970
28,435
32,358
32,287
18,964
5.6%
13Income tax expense
(4,363)
(4,790)
(3,200)
(3,562)
(3,742)
(4,973)
(4,578)
(5,704)
(5,968)
(4,829)
(1,890)
(8)%
14Net Income
5,813
7,017
10,558
11,986
13,839
15,403
17,285
20,120
22,381
14,405
12,056
7.6%
15% Margin
3.7%
3.8%
5.3%
5.3%
5.7%
6%
6%
6.2%
6%
3.6%
2.7%
4.9% A
16Shares Outstanding
967
968
985
983
966
961
956
950
938
929
910
(0.6)%
17EPS Basic
6.1
7.4
11
12.5
14.6
16.3
18.3
21.5
24.1
15.6
13.2
8.1%
18EPS Diluted
6
7.3
10.7
12.2
14.3
16
18.1
21.2
23.9
15.5
13.2
8.2%
19EBITDA
12,714
14,985
17,454
19,772
22,405
25,296
27,073
31,835
36,330
28,076
23,060
6.1%
% Margin
8.1%
8.1%
8.7%
8.7%
9.3%
9.8%
9.4%
9.8%
9.8%
7%
5.2%
8.5% A
20Net Interest Income (expense)
(790)
(1,067)
(1,186)
(1,400)
(1,704)
(1,663)
(1,660)
(2,092)
(3,246)
(3,906)
(4,002)
17.6%
21Net Debt / EBITDA
1.7
1.5
1.1
1.3
1.3
1
0.9
1.1
1.2
1.8
2.3
1.4 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
10,923
10,430
11,981
10,866
10,985
16,921
21,375
23,365
25,427
25,312
24,365
8.4%
23Short-term investments
1,988
2,845
3,509
3,458
3,260
2,860
2,532
4,546
4,201
3,801
3,756
6.6%
24Accounts receivable
6,523
8,152
9,568
11,388
11,822
12,870
28,082
30,450
38,970
48,454
52,715
23.2%
25Other current assets
12,205
12,321
12,026
12,980
16,567
21,067
9,769
10,708
9,839
8,212
9,746
(2.2)%
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
31,639
33,748
37,084
38,692
42,634
53,718
61,758
69,069
78,437
85,779
90,582
11.1%
Non-Current Assets
28Net property, plant & equipment
4,861
5,901
7,013
8,458
8,704
8,626
8,969
10,128
11,450
10,553
10,762
8.3%
29Long-term investments
18,792
23,868
28,341
32,510
37,209
41,242
43,114
43,728
47,609
52,354
54,251
11.2%
30Other non-current assets
56,091
59,162
66,619
72,561
85,342
93,703
98,365
122,780
136,224
149,592
153,986
10.6%
31Total Non-Current Assets
79,744
88,931
101,973
113,529
131,255
143,571
150,448
176,636
195,283
212,499
218,999
10.6%
Total Assets
111,383
122,679
139,057
152,221
173,889
197,289
212,206
245,705
273,720
298,278
309,581
10.8%
LIABILITIES
Current Liabilities
32Accounts payable
26,324
29,752
33,051
36,596
40,695
44,367
49,126
56,771
31,958
68,561
77,369
11.4%
33Short-term debt
6,634
7,193
2,857
1,973
3,870
4,819
3,620
3,110
5,312
4,545
6,069
(0.9)%
34Other current liabilities
9,940
12,270
14,555
14,640
17,217
23,234
25,546
29,356
61,784
30,663
31,459
12.2%
35Total Current Liabilities
42,898
49,215
50,463
53,209
61,782
72,420
78,292
89,237
99,054
103,769
114,897
10.4%
Non-Current Liabilities
36Long-term debt
25,331
25,777
28,835
34,581
36,808
38,648
42,383
54,513
62,123
72,359
72,320
11.1%
37Other non-current liabilities
7,693
7,278
7,737
8,204
13,137
15,682
15,052
15,608
18,319
19,559
20,666
10.4%
38Total Non-Current Liabilities
33,024
33,055
36,572
42,785
49,945
54,330
57,435
70,121
80,442
91,918
92,986
10.9%
39Total Liabilities
75,922
82,270
87,035
95,994
111,727
126,750
135,727
159,358
174,801
195,687
207,883
10.6%
SHAREHOLDERS` EQUITY
40Common stock
10
10
10
10
9
10
10
9
9
9
9
(1.1)%
41Retained earnings / (deficit)
37,125
40,945
48,730
55,846
61,178
69,295
77,134
86,156
95,774
96,036
95,603
9.9%
42Accumulated other comprehensive income / (loss)
(3,334)
(2,681)
(2,667)
(4,160)
(3,578)
(3,814)
(5,384)
(8,393)
(7,027)
(3,387)
(2,061)
(4.7)%
43Noncontrolling interests
1,736
2,012
2,189
4,531
4,546
5,048
4,719
8,575
10,163
9,933
7,588
15.9%
44Total shareholders' equity
35,461
40,409
52,022
56,227
62,162
70,539
76,479
86,347
98,919
102,591
101,698
11.1%
45Total Liabilities and shareholders' Equity
111,383
122,679
139,057
152,221
173,889
197,289
212,206
245,705
273,720
298,278
309,581
10.8%
46Total Debt
32,094
32,970
31,692
36,554
40,678
43,467
46,003
57,623
67,435
76,904
78,389
9.3%
47Net Debt
21,171
22,540
19,711
25,688
29,693
26,546
24,628
34,258
42,008
51,592
54,024
9.8%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
5,813
7,017
10,558
11,986
13,839
15,403
17,285
20,120
22,381
14,405
12,056
7.6%
49Depreciation & amortization
1,693
2,055
2,245
2,428
2,720
2,891
3,103
3,400
3,972
4,099
4,361
9.9%
50Share-based compensation expense
406
485
597
638
697
679
800
925
1,059
1,018
971
9.1%
51Changes in working capital and other assets
1,828
238
196
661
1,207
3,201
1,155
1,761
1,656
4,682
2,309
2.4%
52Net cash flows from operating activities
9,740
9,795
13,596
15,713
18,463
22,174
22,343
26,206
29,068
24,204
19,697
7.3%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(1,556)
(1,705)
(2,023)
(2,063)
(2,071)
(2,051)
(2,454)
(2,802)
(3,386)
(3,499)
(3,622)
8.8%
54Purchases of investments / marketable securities
(531)
(5,927)
(4,319)
(4,099)
(2,504)
(16,577)
(1,843)
(18,825)
(18,314)
(27,308)
-
-
55Proceeds from maturities of marketable securities
9,408
11,620
10,269
9,911
15,627
13,741
15,296
11,988
16,537
27,833
361
(27.8)%
56Other investing activities
(25,716)
(13,343)
(12,526)
(16,134)
(23,751)
(7,645)
(21,371)
(18,837)
(10,411)
(17,553)
(5,424)
(14.4)%
57Net cash flows from investing activities
(18,395)
(9,355)
(8,599)
(12,385)
(12,699)
(12,532)
(10,372)
(28,476)
(15,574)
(20,527)
(8,685)
(7.2)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(798)
(851)
(812)
(3,662)
(4,463)
(2,810)
(3,645)
(5,747)
(6,647)
(7,154)
(5,545)
21.4%
59Dividends paid, net
(1,786)
(2,261)
(2,773)
(3,320)
(3,932)
(4,584)
(5,280)
(5,991)
(6,761)
(7,533)
(7,916)
16.1%
60Debt issuance (repayments), net
14,607
990
(2,615)
4,134
3,994
2,586
2,481
12,536
4,280
14,660
726
(25.9)%
61Other financing activities
216
1,111
2,759
(1,517)
(1,224)
1,218
(1,011)
3,428
(2,401)
(3,485)
1,091
17.6%
62Net cash flows from financing activities
12,239
(1,011)
(3,441)
(4,365)
(5,625)
(3,590)
(7,455)
4,226
(11,529)
(3,512)
(11,644)
-
63Increase (decrease) in cash and cash equivalents
3,428
(493)
1,551
(1,115)
119
5,936
4,454
1,990
2,062
(115)
2,809
(2)%
64Cash and equivalents, ending balance
10,923
10,430
11,981
10,866
10,985
16,921
21,375
23,365
25,427
25,312
28,121
9.9%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
8,184
8,090
11,573
13,650
16,392
20,123
19,889
23,404
25,682
20,705
16,075
7%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

UnitedHealth Group (UNH) financial statements and performance

Explore UnitedHealth Group (UNH) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.